z-logo
open-access-imgOpen Access
EPEN-03. USP7 is an interaction partner of EZHIP and potential druggable target in PFA ependymomas
Author(s) -
Anne Jenseit,
Aylin Camgöz,
Monika Mauermann,
Stefan M. Pfister,
Marcel Kool
Publication year - 2022
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noac079.140
Subject(s) - druggability , ezh2 , gene knockdown , cancer research , radioresistance , epigenetics , ubiquitin , chemistry , deubiquitinating enzyme , biology , computational biology , cell culture , genetics , biochemistry , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom